Covid-19 Impact on Infectious Disease Diagnostic Market, Global Research Reports 2020-2021
This report covers market size and forecasts of Infectious Disease Diagnostic, including the following market information:
Major competitors identified in this market include Roche, BioMrieux SA, Bio-Rad Laboratories, Danaher Corporation, Becton, Dickinson and Company, Cepheid, Abbott, DiaSorin., etc.
Based on the Region:
- Global Infectious Disease Diagnostic Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Infectious Disease Diagnostic Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Infectious Disease Diagnostic Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Infectious Disease Diagnostic Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Major competitors identified in this market include Roche, BioMrieux SA, Bio-Rad Laboratories, Danaher Corporation, Becton, Dickinson and Company, Cepheid, Abbott, DiaSorin., etc.
Based on the Region:
- Asia-Pacific (China, Japan, South Korea, India and ASEAN)
- North America (US and Canada)
- Europe (Germany, France, UK and Italy)
- Rest of World (Latin America, Middle East & Africa)
- Instruments
- Consumables
- Software and Services
- Hepatitis B virus (HBV)
- Hepatitis C virus (HCV)
- Acquired Immunodeficiency Syndrome (AIDS)
- Tuberculosis (TB)
- Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
- Human Papillomavirus (HPV) infection
- Others
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Infectious Disease Diagnostic Industry
1.7 COVID-19 Impact: Infectious Disease Diagnostic Market Trends
2 GLOBAL INFECTIOUS DISEASE DIAGNOSTIC QUARTERLY MARKET SIZE ANALYSIS
2.1 Infectious Disease Diagnostic Business Impact Assessment - COVID-19
2.1.1 Global Infectious Disease Diagnostic Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Infectious Disease Diagnostic Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Infectious Disease Diagnostic Quarterly Market Size, 2019 VS 2020
3.2 By Players, Infectious Disease Diagnostic Headquarters and Area Served
3.3 Date of Key Players Enter into Infectious Disease Diagnostic Market
3.4 Key Players Infectious Disease Diagnostic Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON INFECTIOUS DISEASE DIAGNOSTIC SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Instruments
1.4.2 Consumables
1.4.3 Software and Services
4.2 By Type, Global Infectious Disease Diagnostic Market Size, 2019-2021
5 IMPACT OF COVID-19 ON INFECTIOUS DISEASE DIAGNOSTIC SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Hepatitis B virus (HBV)
5.5.2 Hepatitis C virus (HCV)
5.5.3 Acquired Immunodeficiency Syndrome (AIDS)
5.5.4 Tuberculosis (TB)
5.5.5 Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
5.5.6 Human Papillomavirus (HPV) infection
5.5.7 Others
5.2 By Application, Global Infectious Disease Diagnostic Market Size, 2019-2021
5.2.1 By Application, Global Infectious Disease Diagnostic Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Roche
7.1.1 Roche Business Overview
7.1.2 Roche Infectious Disease Diagnostic Quarterly Revenue, 2020
7.1.3 Roche Infectious Disease Diagnostic Product Introduction
7.1.4 Roche Response to COVID-19 and Related Developments
7.2 BioMrieux SA
7.2.1 BioMrieux SA Business Overview
7.2.2 BioMrieux SA Infectious Disease Diagnostic Quarterly Revenue, 2020
7.2.3 BioMrieux SA Infectious Disease Diagnostic Product Introduction
7.2.4 BioMrieux SA Response to COVID-19 and Related Developments
7.3 Bio-Rad Laboratories
7.3.1 Bio-Rad Laboratories Business Overview
7.3.2 Bio-Rad Laboratories Infectious Disease Diagnostic Quarterly Revenue, 2020
7.3.3 Bio-Rad Laboratories Infectious Disease Diagnostic Product Introduction
7.3.4 Bio-Rad Laboratories Response to COVID-19 and Related Developments
7.4 Danaher Corporation
7.4.1 Danaher Corporation Business Overview
7.4.2 Danaher Corporation Infectious Disease Diagnostic Quarterly Revenue, 2020
7.4.3 Danaher Corporation Infectious Disease Diagnostic Product Introduction
7.4.4 Danaher Corporation Response to COVID-19 and Related Developments
7.5 Becton
7.5.1 Becton Business Overview
7.5.2 Becton Infectious Disease Diagnostic Quarterly Revenue, 2020
7.5.3 Becton Infectious Disease Diagnostic Product Introduction
7.5.4 Becton Response to COVID-19 and Related Developments
7.6 Dickinson and Company
7.6.1 Dickinson and Company Business Overview
7.6.2 Dickinson and Company Infectious Disease Diagnostic Quarterly Revenue, 2020
7.6.3 Dickinson and Company Infectious Disease Diagnostic Product Introduction
7.6.4 Dickinson and Company Response to COVID-19 and Related Developments
7.7 Cepheid
7.7.1 Cepheid Business Overview
7.7.2 Cepheid Infectious Disease Diagnostic Quarterly Revenue, 2020
7.7.3 Cepheid Infectious Disease Diagnostic Product Introduction
7.7.4 Cepheid Response to COVID-19 and Related Developments
7.8 Abbott
7.8.1 Abbott Business Overview
7.8.2 Abbott Infectious Disease Diagnostic Quarterly Revenue, 2020
7.8.3 Abbott Infectious Disease Diagnostic Product Introduction
7.8.4 Abbott Response to COVID-19 and Related Developments
7.9 DiaSorin.
7.9.1 DiaSorin. Business Overview
7.9.2 DiaSorin. Infectious Disease Diagnostic Quarterly Revenue, 2020
7.9.3 DiaSorin. Infectious Disease Diagnostic Product Introduction
7.9.4 DiaSorin. Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Infectious Disease Diagnostic Industry
1.7 COVID-19 Impact: Infectious Disease Diagnostic Market Trends
2 GLOBAL INFECTIOUS DISEASE DIAGNOSTIC QUARTERLY MARKET SIZE ANALYSIS
2.1 Infectious Disease Diagnostic Business Impact Assessment - COVID-19
2.1.1 Global Infectious Disease Diagnostic Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Infectious Disease Diagnostic Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Infectious Disease Diagnostic Quarterly Market Size, 2019 VS 2020
3.2 By Players, Infectious Disease Diagnostic Headquarters and Area Served
3.3 Date of Key Players Enter into Infectious Disease Diagnostic Market
3.4 Key Players Infectious Disease Diagnostic Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON INFECTIOUS DISEASE DIAGNOSTIC SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Instruments
1.4.2 Consumables
1.4.3 Software and Services
4.2 By Type, Global Infectious Disease Diagnostic Market Size, 2019-2021
5 IMPACT OF COVID-19 ON INFECTIOUS DISEASE DIAGNOSTIC SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Hepatitis B virus (HBV)
5.5.2 Hepatitis C virus (HCV)
5.5.3 Acquired Immunodeficiency Syndrome (AIDS)
5.5.4 Tuberculosis (TB)
5.5.5 Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
5.5.6 Human Papillomavirus (HPV) infection
5.5.7 Others
5.2 By Application, Global Infectious Disease Diagnostic Market Size, 2019-2021
5.2.1 By Application, Global Infectious Disease Diagnostic Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Roche
7.1.1 Roche Business Overview
7.1.2 Roche Infectious Disease Diagnostic Quarterly Revenue, 2020
7.1.3 Roche Infectious Disease Diagnostic Product Introduction
7.1.4 Roche Response to COVID-19 and Related Developments
7.2 BioMrieux SA
7.2.1 BioMrieux SA Business Overview
7.2.2 BioMrieux SA Infectious Disease Diagnostic Quarterly Revenue, 2020
7.2.3 BioMrieux SA Infectious Disease Diagnostic Product Introduction
7.2.4 BioMrieux SA Response to COVID-19 and Related Developments
7.3 Bio-Rad Laboratories
7.3.1 Bio-Rad Laboratories Business Overview
7.3.2 Bio-Rad Laboratories Infectious Disease Diagnostic Quarterly Revenue, 2020
7.3.3 Bio-Rad Laboratories Infectious Disease Diagnostic Product Introduction
7.3.4 Bio-Rad Laboratories Response to COVID-19 and Related Developments
7.4 Danaher Corporation
7.4.1 Danaher Corporation Business Overview
7.4.2 Danaher Corporation Infectious Disease Diagnostic Quarterly Revenue, 2020
7.4.3 Danaher Corporation Infectious Disease Diagnostic Product Introduction
7.4.4 Danaher Corporation Response to COVID-19 and Related Developments
7.5 Becton
7.5.1 Becton Business Overview
7.5.2 Becton Infectious Disease Diagnostic Quarterly Revenue, 2020
7.5.3 Becton Infectious Disease Diagnostic Product Introduction
7.5.4 Becton Response to COVID-19 and Related Developments
7.6 Dickinson and Company
7.6.1 Dickinson and Company Business Overview
7.6.2 Dickinson and Company Infectious Disease Diagnostic Quarterly Revenue, 2020
7.6.3 Dickinson and Company Infectious Disease Diagnostic Product Introduction
7.6.4 Dickinson and Company Response to COVID-19 and Related Developments
7.7 Cepheid
7.7.1 Cepheid Business Overview
7.7.2 Cepheid Infectious Disease Diagnostic Quarterly Revenue, 2020
7.7.3 Cepheid Infectious Disease Diagnostic Product Introduction
7.7.4 Cepheid Response to COVID-19 and Related Developments
7.8 Abbott
7.8.1 Abbott Business Overview
7.8.2 Abbott Infectious Disease Diagnostic Quarterly Revenue, 2020
7.8.3 Abbott Infectious Disease Diagnostic Product Introduction
7.8.4 Abbott Response to COVID-19 and Related Developments
7.9 DiaSorin.
7.9.1 DiaSorin. Business Overview
7.9.2 DiaSorin. Infectious Disease Diagnostic Quarterly Revenue, 2020
7.9.3 DiaSorin. Infectious Disease Diagnostic Product Introduction
7.9.4 DiaSorin. Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
LIST OF TABLES
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Infectious Disease Diagnostic Assessment
Table 9. COVID-19 Impact: Infectious Disease Diagnostic Market Trends
Table 10. COVID-19 Impact Global Infectious Disease Diagnostic Market Size
Table 11. Global Infectious Disease Diagnostic Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Infectious Disease Diagnostic Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Infectious Disease Diagnostic Market Growth Drivers
Table 14. Global Infectious Disease Diagnostic Market Restraints
Table 15. Global Infectious Disease Diagnostic Market Opportunities
Table 16. Global Infectious Disease Diagnostic Market Challenges
Table 17. By Players, Infectious Disease Diagnostic Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Infectious Disease Diagnostic Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Infectious Disease Diagnostic Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Infectious Disease Diagnostic Market
Table 21. Key Players Infectious Disease Diagnostic Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Infectious Disease Diagnostic Market Size 2019-2021, (US$ Million)
Table 24. Global Infectious Disease Diagnostic Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Infectious Disease Diagnostic Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 57. Roche Business Overview
Table 58. Roche Infectious Disease Diagnostic Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Roche Infectious Disease Diagnostic Product
Table 60. Roche Response to COVID-19 and Related Developments
Table 61. BioMrieux SA Business Overview
Table 62. BioMrieux SA Infectious Disease Diagnostic Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. BioMrieux SA Infectious Disease Diagnostic Product
Table 64. BioMrieux SA Response to COVID-19 and Related Developments
Table 65. Bio-Rad Laboratories Business Overview
Table 66. Bio-Rad Laboratories Infectious Disease Diagnostic Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Bio-Rad Laboratories Infectious Disease Diagnostic Product
Table 68. Bio-Rad Laboratories Response to COVID-19 and Related Developments
Table 69. Danaher Corporation Business Overview
Table 70. Danaher Corporation Infectious Disease Diagnostic Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Danaher Corporation Infectious Disease Diagnostic Product
Table 72. Danaher Corporation Response to COVID-19 and Related Developments
Table 73. Becton Business Overview
Table 74. Becton Infectious Disease Diagnostic Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Becton Infectious Disease Diagnostic Product
Table 76. Becton Response to COVID-19 and Related Developments
Table 77. Dickinson and Company Business Overview
Table 78. Dickinson and Company Infectious Disease Diagnostic Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Dickinson and Company Infectious Disease Diagnostic Product
Table 80. Dickinson and Company Response to COVID-19 and Related Developments
Table 81. Cepheid Business Overview
Table 82. Cepheid Infectious Disease Diagnostic Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Cepheid Infectious Disease Diagnostic Product
Table 84. Cepheid Response to COVID-19 and Related Developments
Table 85. Abbott Business Overview
Table 86. Abbott Infectious Disease Diagnostic Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Abbott Infectious Disease Diagnostic Product
Table 88. Abbott Response to COVID-19 and Related Developments
Table 89. DiaSorin. Business Overview
Table 90. DiaSorin. Infectious Disease Diagnostic Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. DiaSorin. Infectious Disease Diagnostic Product
Table 92. DiaSorin. Response to COVID-19 and Related Developments
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Infectious Disease Diagnostic Assessment
Table 9. COVID-19 Impact: Infectious Disease Diagnostic Market Trends
Table 10. COVID-19 Impact Global Infectious Disease Diagnostic Market Size
Table 11. Global Infectious Disease Diagnostic Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Infectious Disease Diagnostic Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Infectious Disease Diagnostic Market Growth Drivers
Table 14. Global Infectious Disease Diagnostic Market Restraints
Table 15. Global Infectious Disease Diagnostic Market Opportunities
Table 16. Global Infectious Disease Diagnostic Market Challenges
Table 17. By Players, Infectious Disease Diagnostic Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Infectious Disease Diagnostic Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Infectious Disease Diagnostic Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Infectious Disease Diagnostic Market
Table 21. Key Players Infectious Disease Diagnostic Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Infectious Disease Diagnostic Market Size 2019-2021, (US$ Million)
Table 24. Global Infectious Disease Diagnostic Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Infectious Disease Diagnostic Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Infectious Disease Diagnostic Market Size, 2019-2021 (US$ Million)
Table 57. Roche Business Overview
Table 58. Roche Infectious Disease Diagnostic Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Roche Infectious Disease Diagnostic Product
Table 60. Roche Response to COVID-19 and Related Developments
Table 61. BioMrieux SA Business Overview
Table 62. BioMrieux SA Infectious Disease Diagnostic Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. BioMrieux SA Infectious Disease Diagnostic Product
Table 64. BioMrieux SA Response to COVID-19 and Related Developments
Table 65. Bio-Rad Laboratories Business Overview
Table 66. Bio-Rad Laboratories Infectious Disease Diagnostic Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Bio-Rad Laboratories Infectious Disease Diagnostic Product
Table 68. Bio-Rad Laboratories Response to COVID-19 and Related Developments
Table 69. Danaher Corporation Business Overview
Table 70. Danaher Corporation Infectious Disease Diagnostic Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Danaher Corporation Infectious Disease Diagnostic Product
Table 72. Danaher Corporation Response to COVID-19 and Related Developments
Table 73. Becton Business Overview
Table 74. Becton Infectious Disease Diagnostic Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Becton Infectious Disease Diagnostic Product
Table 76. Becton Response to COVID-19 and Related Developments
Table 77. Dickinson and Company Business Overview
Table 78. Dickinson and Company Infectious Disease Diagnostic Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Dickinson and Company Infectious Disease Diagnostic Product
Table 80. Dickinson and Company Response to COVID-19 and Related Developments
Table 81. Cepheid Business Overview
Table 82. Cepheid Infectious Disease Diagnostic Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Cepheid Infectious Disease Diagnostic Product
Table 84. Cepheid Response to COVID-19 and Related Developments
Table 85. Abbott Business Overview
Table 86. Abbott Infectious Disease Diagnostic Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Abbott Infectious Disease Diagnostic Product
Table 88. Abbott Response to COVID-19 and Related Developments
Table 89. DiaSorin. Business Overview
Table 90. DiaSorin. Infectious Disease Diagnostic Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. DiaSorin. Infectious Disease Diagnostic Product
Table 92. DiaSorin. Response to COVID-19 and Related Developments
LIST OF FIGURES
Figure 1. Infectious Disease Diagnostic Product Picture
Figure 2. Infectious Disease Diagnostic Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Infectious Disease Diagnostic Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Infectious Disease Diagnostic Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Infectious Disease Diagnostic Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Infectious Disease Diagnostic Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Infectious Disease Diagnostic Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Infectious Disease Diagnostic Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Infectious Disease Diagnostic Market Size Market Share, 2019-2021
Figure 1. Infectious Disease Diagnostic Product Picture
Figure 2. Infectious Disease Diagnostic Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Infectious Disease Diagnostic Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Infectious Disease Diagnostic Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Infectious Disease Diagnostic Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Infectious Disease Diagnostic Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Infectious Disease Diagnostic Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Infectious Disease Diagnostic Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Infectious Disease Diagnostic Market Size Market Share, 2019-2021
